Dalcin D, Kwong JC. High-dose influenza vaccination. CMAJ. 2019 Mar 18;191(11):E313
High-dose trivalent inactivated influenza vaccine (HD-TIV) contains 60 μg of hemagglutinin per strain, whereas standard-dose vaccines (SD-TIV) contain 15 μg. Given the burden of influenza A subtype H3N2 in older adults and evidence of better efficacy of HD-TIV relative to SD-TIV (Box 1),1–4 Canada’s National Advisory Committee on Immunization recommends HD-TIV over SD-TIV for adults aged 65 years and older; however, the comparative effectiveness of HD-TIV over other options (MF59-adjuvanted TIV or standard-dose quadrivalent influenza vaccine) is uncertain.5 The HD-TIV is publicly funded for adults aged 65 and older in Ontario and for long-term care residents aged 65 and older in Saskatchewan, Manitoba and Prince Edward Island.
See Also:
Latest articles in those days:
- The evolution, complexity, and diversity of swine influenza viruses in China: A hidden public health threat 22 hours ago
- MHC class II proteins mediate sialic acid independent entry of human and avian H2N2 influenza A viruses 22 hours ago
- Histopathologic Features and Viral Antigen Distribution of H5N1 Highly Pathogenic Avian Influenza Virus Clade 2.3.4.4b from the 2022–2023 Outbreak in Iowa Wild Birds 22 hours ago
- Detection and characterization of H5N1 HPAIV in environmental samples from a dairy farm 1 days ago
- Genomic Characterization of Highly Pathogenic Avian Influenza A H5N1 Virus Newly Emerged in Dairy Cattle 1 days ago
[Go Top] [Close Window]